Autobio Diagnostics Co., Ltd. (603658.SS)
CNY 44.66
(-3.17%)
CNY 44.66
(-3.17%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 778.28 Million CNY | 3.45% |
| 2022 | 752.3 Million CNY | 27.65% |
| 2021 | 589.34 Million CNY | 23.94% |
| 2020 | 475.52 Million CNY | 38.95% |
| 2019 | 342.21 Million CNY | 33.49% |
| 2018 | 256.35 Million CNY | 32.47% |
| 2017 | 193.52 Million CNY | 109.15% |
| 2016 | 92.52 Million CNY | 10.65% |
| 2015 | 83.62 Million CNY | 32.4% |
| 2014 | 63.15 Million CNY | -22.93% |
| 2013 | 81.94 Million CNY | 54.32% |
| 2012 | 53.1 Million CNY | 54.63% |
| 2011 | 34.33 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 884.84 Million CNY | 6.17% |
| 2024 Q1 | 833.39 Million CNY | 7.08% |
| 2024 Q3 | 931.11 Million CNY | 5.23% |
| 2023 Q3 | 748.79 Million CNY | 3.15% |
| 2023 Q4 | 778.28 Million CNY | 3.94% |
| 2023 FY | 778.28 Million CNY | 3.45% |
| 2023 Q1 | 687.57 Million CNY | -8.6% |
| 2023 Q2 | 725.93 Million CNY | 5.58% |
| 2022 Q4 | 752.3 Million CNY | -4.45% |
| 2022 Q3 | 787.3 Million CNY | 4.55% |
| 2022 Q2 | 753.01 Million CNY | 10.56% |
| 2022 FY | 752.3 Million CNY | 27.65% |
| 2022 Q1 | 681.06 Million CNY | 15.56% |
| 2021 Q1 | 480.89 Million CNY | 1.13% |
| 2021 Q3 | 588.52 Million CNY | 7.31% |
| 2021 Q4 | 589.34 Million CNY | 0.14% |
| 2021 FY | 589.34 Million CNY | 23.94% |
| 2021 Q2 | 548.42 Million CNY | 14.04% |
| 2020 Q2 | 456.43 Million CNY | 17.04% |
| 2020 Q3 | 523.6 Million CNY | 14.71% |
| 2020 FY | 475.52 Million CNY | 38.95% |
| 2020 Q4 | 475.52 Million CNY | -9.18% |
| 2020 Q1 | 389.97 Million CNY | 13.95% |
| 2019 Q4 | 342.21 Million CNY | 7.0% |
| 2019 FY | 342.21 Million CNY | 33.49% |
| 2019 Q3 | 319.82 Million CNY | 7.77% |
| 2019 Q2 | 296.76 Million CNY | 8.59% |
| 2019 Q1 | 273.28 Million CNY | 6.6% |
| 2018 Q2 | 241.8 Million CNY | 16.11% |
| 2018 Q4 | 256.35 Million CNY | -2.02% |
| 2018 FY | 256.35 Million CNY | 32.47% |
| 2018 Q3 | 261.63 Million CNY | 8.2% |
| 2018 Q1 | 208.25 Million CNY | 7.61% |
| 2017 Q2 | 132.05 Million CNY | 12.22% |
| 2017 Q1 | 117.67 Million CNY | 27.17% |
| 2017 Q3 | 154.35 Million CNY | 16.88% |
| 2017 Q4 | 193.52 Million CNY | 25.38% |
| 2017 FY | 193.52 Million CNY | 109.15% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q3 | 106.15 Million CNY | 14.99% |
| 2016 Q4 | 92.52 Million CNY | -12.83% |
| 2016 FY | 92.52 Million CNY | 10.65% |
| 2016 Q2 | 92.31 Million CNY | 0.0% |
| 2015 Q1 | 79.99 Million CNY | 0.0% |
| 2015 FY | 83.62 Million CNY | 32.4% |
| 2015 Q4 | 83.62 Million CNY | 0.0% |
| 2015 Q2 | 79.99 Million CNY | 0.0% |
| 2015 Q3 | - CNY | -100.0% |
| 2014 FY | 63.15 Million CNY | -22.93% |
| 2013 FY | 81.94 Million CNY | 54.32% |
| 2012 FY | 53.1 Million CNY | 54.63% |
| 2011 FY | 34.33 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 1.37 Billion CNY | 43.477% |
| Joinn Laboratories(China)Co.,Ltd. | 1.86 Billion CNY | 58.226% |
| WuXi AppTec Co., Ltd. | 4.73 Billion CNY | 83.567% |
| Thalys Medical Technology Group Inc. | 341.6 Million CNY | -127.835% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 248.2 Million CNY | -213.564% |
| Chemclin Diagnostics Co., Ltd. | 110.6 Million CNY | -603.663% |